Pamyl (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pamyl, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pamyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours. - Peptic ulcer disease (duodenal and gastric): supports ulcer healing and prevents relapse.

Adverse reactions to pantoprazole are generally mild, but they can vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools without blood. - Nausea: occasional feeling of queasiness. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea with abdominal pain. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Liver enzyme elevation: asymptomatic rise in ALT/AST. - Fracture risk with long‑term use: decreased bone mineral density.

When prescribing pantoprazole, clinicians should consider several safety aspects: - Renal impairment: dose adjustment may be required in severe kidney disease. - Hepatic impairment: monitor liver function in patients with existing liver disease. - Long‑term therapy: assess need for periodic review to avoid unnecessary prolonged exposure. - Drug‑induced nutrient deficiencies: monitor magnesium and vitamin B12 levels during extended use. - Pregnancy and lactation: use only if the potential benefit outweighs the risk. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Pantoprazole may affect the pharmacokinetics of several co‑administered medicines. Awareness of the interaction potential helps optimise therapy.

Major Interactions (Avoid): - Ketoconazole and itraconazole: reduced antifungal absorption due to increased gastric pH. - Atazanavir: markedly decreased antiretroviral exposure, risking treatment failure. - Clopidogrel: diminished activation leading to reduced antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Methotrexate: reduced renal clearance may raise serum levels. - Digoxin: slight increase in serum concentration; observe for toxicity signs.